X-8170151-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000317103.5(VCX2):āc.301C>Gā(p.His101Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H101Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000317103.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCX2 | NM_016378.3 | c.301C>G | p.His101Asp | missense_variant | 3/3 | ENST00000317103.5 | NP_057462.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCX2 | ENST00000317103.5 | c.301C>G | p.His101Asp | missense_variant | 3/3 | 1 | NM_016378.3 | ENSP00000321309.4 | ||
ENSG00000285679 | ENST00000649338.1 | n.263-58184G>C | intron_variant | |||||||
ENSG00000285679 | ENST00000659022.1 | n.972-58184G>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 1AN: 56162Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6516
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000190 AC: 20AN: 1054941Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 337033
GnomAD4 genome AF: 0.0000178 AC: 1AN: 56162Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.301C>G (p.H101D) alteration is located in exon 3 (coding exon 2) of the VCX2 gene. This alteration results from a C to G substitution at nucleotide position 301, causing the histidine (H) at amino acid position 101 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at